Elisabeth Adderson

Title: Elisabeth Adderson: Innovator in Streptococcal Research

Introduction

Elisabeth Adderson is a prominent inventor based in Memphis, TN (US). She has made significant contributions to the field of microbiology, particularly in the study of streptococcal infections. With a total of 4 patents to her name, her work focuses on the development of therapeutic methods and compositions to combat these infections.

Latest Patents

Her latest patents include innovations that provide isolated nucleic acids encoding polypeptides comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides. These inventions specifically address Group B streptococcal Ema polypeptides EmaA, EmaB, EmaC, EmaD, and EmaE. The patents also cover isolated polypeptides, including analogs, variants, mutants, derivatives, and fragments thereof. Furthermore, her inventions relate to the identification and prevention of infections caused by virulent forms of streptococci. They encompass pharmaceutical compositions, immunogenic compositions, vaccines, and diagnostic and therapeutic methods utilizing the isolated polypeptides and antibodies.

Career Highlights

Elisabeth has worked with notable institutions such as St. Jude Children's Research Hospital and the University of Utah Research Foundation. Her research has been pivotal in advancing the understanding of streptococcal infections and developing effective treatments.

Collaborations

Throughout her career, Elisabeth has collaborated with esteemed colleagues, including John Bohnsack and Linda Jeannine Brady. These partnerships have further enriched her research and contributions to the field.

Conclusion

Elisabeth Adderson's innovative work in streptococcal research has led to significant advancements in the identification and treatment of infections. Her contributions continue to impact the medical field positively.